60 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... #Pharmacology # ... Dosing #Dosing # ... Impairment #CKD #Table
REBEL Review 4 & 5: Paralytic & Vasopressor Dosing 

Paralytic Agents:
 - Succinylcholine (Depolarizing Agent)
& Vasopressor Dosing ... resuscitation #table ... #criticalcare # ... pharmacology #dosing
Insulin and analogues onset of action, peak times and duration.

Follow at www.instagram.com/rxnotes for more!

#pharmacology #table #comparison
#pharmacology #table ... #comparison #dosing ... #insulin #diabetes
Pharmacologic prophylaxis of VTE in selected clinical scenarios.

Enoxaparin 
Dalteparin 
Fondaparinux 
Dabigatran 
Unfractionated Heparin
Warfarin 
Aspirin 

#prophylaxis #VTE
Pharmacologic prophylaxis ... VTE in selected clinical ... prophylaxis #VTE #DVT #dosing ... #indications #pharmacology ... #table
Insulin Dosing Basics - Initiating Insulin for T2DM and Converting Insulin Products 

Insulin dosing can be
Insulin Dosing Basics ... For type 2 diabetes ... insulin for type 2 diabetes ... run into patient cases ... #Prescribing #Pharmacology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... kidney), which causes ... glucose in the urine ... excretion in the urine ... SGLT2 #Inhibitors #Pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Medication Guide Classes ... insulin in Type 1 Diabetes ... #Medications #pharmacology ... #comparison #table
Erythema Nodosum - Causes and Differential Diagnosis 
Appearance:  erythematous painful lumps usually 1-6 cm in
Erythema Nodosum - Causes ... usually 1-6 cm in diameter ... around the areas during ... Erythema #Nodosum #Causes ... Dermatology #SkinRash #Clinical
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Januvia) - Once/day tablet ... not definitively cause ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 #diabetes
Diabetic Ketoacidosis (DKA) - Pathogenesis and Clinical Findings
 • Note: in DKA, body K+ is lost
Diabetic Ketoacidosis ... Pathogenesis and Clinical ... out of cells may cause ... renal function/urine ... endocrinology #diabetes